1. Home
  2. OFS vs DRIO Comparison

OFS vs DRIO Comparison

Compare OFS & DRIO Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo OFS Capital Corporation

OFS

OFS Capital Corporation

HOLD

Current Price

$3.57

Market Cap

54.3M

Sector

Finance

ML Signal

HOLD

Logo DarioHealth Corp.

DRIO

DarioHealth Corp.

HOLD

Current Price

$7.37

Market Cap

52.8M

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
OFS
DRIO
Founded
2001
2011
Country
United States
United States
Employees
N/A
N/A
Industry
Finance/Investors Services
Medical/Dental Instruments
Sector
Finance
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
54.3M
52.8M
IPO Year
2010
2013

Fundamental Metrics

Financial Performance
Metric
OFS
DRIO
Price
$3.57
$7.37
Analyst Decision
Strong Buy
Analyst Count
0
2
Target Price
N/A
$35.00
AVG Volume (30 Days)
51.4K
26.8K
Earning Date
04-30-2026
05-14-2026
Dividend Yield
16.83%
N/A
EPS Growth
N/A
1559.02
EPS
N/A
1.75
Revenue
N/A
$7,394,000.00
Revenue This Year
N/A
$20.27
Revenue Next Year
N/A
$47.58
P/E Ratio
N/A
$4.10
Revenue Growth
N/A
43.02
52 Week Low
$2.72
$0.43
52 Week High
$8.99
$17.74

Technical Indicators

Market Signals
Indicator
OFS
DRIO
Relative Strength Index (RSI) 48.13 50.07
Support Level $3.26 $7.18
Resistance Level $3.85 $8.29
Average True Range (ATR) 0.20 0.81
MACD -0.00 -0.03
Stochastic Oscillator 46.88 56.22

Price Performance

Historical Comparison
OFS
DRIO

About OFS OFS Capital Corporation

OFS Capital Corp is an externally managed, closed-end, non-diversified management investment company. Its investment objective is to provide its stockholders with both current income and capital appreciation through debt investments and, to a lesser extent, equity investments.

About DRIO DarioHealth Corp.

DarioHealth Corp is a digital therapeutics (DTx) company delivering personalized evidence-based interventions that are driven by precision data analytics, software, and personalized coaching. The company vertically integrated a health intelligence platform with a mission to power the behavior changes that drive greater health. Unlike software-only digital health platforms, Dario owns the complete chain of value in chronic care management - connected FDA-cleared hardware devices that generate continuous physiological data, and AI built on that proprietary data. The company focuses on delivering user experiences, longer sustained engagement, and stronger clinical outcomes, at affordable prices, which then delivers the highest return on investment in the industry.

Share on Social Networks: